{"id":2196405,"date":"2024-03-11T12:07:02","date_gmt":"2024-03-11T16:07:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk-in-overweight-adults\/"},"modified":"2024-03-11T12:09:28","modified_gmt":"2024-03-11T16:09:28","slug":"fda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk-in-overweight-adults","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/fda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk-in-overweight-adults\/","title":{"rendered":"FDA approves Wegovy to lower heart attack and stroke risk in overweight adults"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">26<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Ffda-approves-wegovy-to-reduce-heart-attack-and-stroke-risk-in-overweight-adults%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2196405&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p><!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\"><br \/>\n<?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><?xml encoding=\"utf-8\" ?><html><body><\/p>\n<div class=\"entry-content\">\n<figure class=\"wp-block-image size-full\"><figcaption class=\"wp-element-caption\">Novo Nordisk\u2019s blockbuster weight\u200c loss\u200b drug Wegovy can now by prescribed to reduce\u200b the risk of heart attack and \u200dstroke. (Michael Siluk \/ Universal Images Group via Getty Images file)<\/figcaption><\/figure>\n<p>OAN\u2019s <a href=\"https:\/\/www.oann.com\/tag\/abril-elfi\" target=\"_blank\" rel=\"noreferrer noopener\">Abril Elfi<\/a><br \/>9:27 AM \u2013 Saturday, \u200dMarch 9, 2024<\/p>\n<h2>The\u2062 FDA Approves\u2064 Wegovy to Reduce \u200cHeart Attack and Stroke \u2064Risk<\/h2>\n<p>The Food and Drug Administration (FDA) has given its approval\u200b to the weight-loss drug Wegovy, allowing it to be prescribed as a means to reduce \u2064the risk of heart attack and\u200d stroke.<\/p>\n<div id=\"div-gpt-ad-1663871513696-art-3\" style=\"min-width: 320px; min-height: 50px; text-align: center;\">  \t<script>  \t\tgoogletag.cmd.push(function() { googletag.display('div-gpt-ad-1663871513696-art-3'); });  \t<\/script>  <\/div>\n<div class=\"ad-slot__ad-label\">Advertisement<\/div>\n<\/p>\n<p>Novo Nordisk, the manufacturer\u2062 of Wegovy, announced on Friday that the FDA has updated the drug&#8217;s label to include \u2063its potential in reducing heart\u2064 issues among overweight adults.<\/p>\n<p>Heart attack is currently \u2062the leading cause of\u2063 death \u200din the United States, \u200daccording to\u200c the Centers for \u200dDisease Control and Prevention (CDC).<\/p>\n<p>This label change was prompted by Novo Nordisk&#8217;s findings from a late-stage clinical trial involving over 17,000 adults with a history of heart disease who were either obese or overweight. The trial\u2063 revealed that Wegovy reduced the risk of cardiovascular\u2064 events, such as heart attacks \u2063and strokes, by 20% compared to a placebo.<\/p>\n<p>As a result of this modification, more insurers and employers \u200bmay now cover the medication.<\/p>\n<p>It is\u200d important\u2062 to note that Medicare is\u200c not permitted to \u200bpay for Wegovy or similar weight-loss drugs like\u200c Eli\u2064 Lilly&#8217;s Zepbound,\u2062 so insurance coverage for \u2062these medications is typically limited.<\/p>\n<p>Novo Nordisk claims that Wegovy is the\u200b first medication authorized \u2064in the\u2064 United States for both weight management and heart disease risk reduction.<\/p>\n<p>Wegovy contains semaglutide,\u200b the active component\u2064 found\u2062 in the well-known diabetes medication \u200dOzempic, which is often used off-label for weight loss.<\/p>\n<p>Stay informed! Subscribe\u2063 here to <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/david-depapes-legal-team-seeks-to-move-trial-from-san-francisco\/\" title=\"David DePape's lawyers aim to relocate trial from San Francisco.\">receive breaking\u200b news blasts directly<\/a> to your inbox for free: <a href=\"https:\/\/www.oann.com\/alerts\">https:\/\/www.oann.com\/alerts<\/a><\/p>\n<\/p>\n<div id=\"rc-widget-10bad2\" data-rc-widget data-widget-host=\"habitat\" data-endpoint=\"\/\/trends.revcontent.com\" data-widget-id=\"278641\"><\/div>\n<p class=\"dpsp-share-text\" style=\"margin-bottom:10px\"> \t\t \t\tShare this post!\t<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>President\u2063 Biden\u2064 mourns the loss of Lincoln Riley at SOTU, Lara Trump becomes \u2064Co-Chair of the RNC\u2064 and Sweet Baby Inc. is exposed.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Joe\u2063 Biden\u2019s speech writers may have their\u200c work cut out for them for the State \u200bof the \u2063Union. One America\u2019s Nathaniel Mannor has more. \u200c <\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>One Christian author explains how trangenderism is hurting\u200d America\u2019s youth, and how Christians can fight back. <\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Arizona is\u2063 facing a host of problems created\u2064 by Democrat policies, especially those created by illegal \u200bimmigration\u2062 at its southern border.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>UnitedHealth Group is likely to need several months to make a full recovery from one of the most disruptive hacks against America\u2019s\u200c healthcare infrastructure.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Google has\u2064 been touting the myriad\u2062 innovations in the first building wholly designed and built by\u200c the web giant.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>Investors \u200chave piled into\u2064 Nvidia-focused\u2062 ETFs this year on the frenzy around AI.<\/p>\n<\/p><\/div>\n<div class=\"entry-content\">\n<p>LinkedIn for the first time\u2063 disclosed sales for its premium subscription business\u2062 as\u2062 the company\u2064 sees an uptick in adoption of new AI\u200b tools.<\/p>\n<\/p><\/div>\n<p> rnrn  <\/p>\n<h2> What are the potential implications of FDA approval and label update for insurance coverage of Wegovy?<\/h2>\n<p><span>  Great\u200d interest to the\u200b medical \u200ccommunity. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by increasing insulin secretion and decreasing glucagon secretion. It has been shown to promote \u2064weight\u200b loss by reducing appetite, increasing satiety, and\u200b improving insulin sensitivity.<\/p>\n<p>The approval of Wegovy by\u2063 the\u2062 FDA is a significant milestone in the\u200b fight against obesity-related health issues. Obesity is a major \u2062risk factor for cardiovascular disease,\u200c including heart attacks and \u200bstrokes. By offering a \u200dweight-loss drug \u200cthat not only \u200bhelps individuals shed \u200cexcess pounds but also reduces their risk of heart attack and stroke, healthcare providers have a valuable tool to combat these life-threatening conditions.<\/p>\n<p>The \u200bclinical trial conducted by Novo Nordisk demonstrated the efficacy and safety of\u200b Wegovy in reducing the incidence of cardiovascular events. With a 20% \u200breduction in risk compared to a placebo, the \u2062drug has proven to be a game-changer in the management of both \u200bobesity and\u2064 heart disease.<\/p>\n<p>In \u200caddition to its benefits for patients, the FDA approval of \u200bWegovy may have significant \u200cimplications in terms of \u200cinsurance coverage. With the\u200b updated label indicating its potential to\u200b reduce heart issues, more insurers and employers may now\u200d consider covering\u2063 the medication.\u2064 This\u2062 is particularly important given the high healthcare costs associated\u2063 with cardiovascular disease.<\/p>\n<p>However, it should\u200c be noted that Medicare, the \u2063federal health insurance program\u200b for Americans aged 65 and older, is not permitted to cover\u200d Wegovy or other similar weight-loss drugs. Insurance coverage for these medications may still be limited, but the FDA \u2063approval and label update open the \u200bdoor for more individuals to have access to this <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/establishment-media-acknowledge-biden-botched-omicron-testing-kit-supply\/\" title=\"Establishment Media Acknowledge Biden Botched Omicron Testing Kit Supply\">potentially life-saving treatment<\/a>.<\/p>\n<p>Novo Nordisk&#8217;s achievement with \u200dWegovy is also \u2063significant from a pharmaceutical\u2064 standpoint. It is the first medication in the United States that\u200d is authorized for both weight\u2064 management \u200band heart disease risk reduction. This highlights the growing \u2064recognition of the complex relationship between obesity and cardiovascular health and underscores the importance of a comprehensive \u200bapproach to tackling \u200bthese interconnected issues.<\/p>\n<p>As we continue to learn more about\u2062 the potential benefits of Wegovy, it is \u2064crucial for healthcare \u2062providers to closely monitor patients using the drug. Like\u200d any medication, it may have side effects \u2064and should be prescribed and monitored by qualified healthcare professionals.<\/p>\n<p>The FDA approval of Wegovy marks a major breakthrough in the treatment\u200b of obesity-related heart issues. By combining weight management and cardiovascular risk reduction into one medication,\u200d Novo Nordisk has opened up new possibilities for patients struggling with both conditions. As more \u200cresearch and clinical trials are conducted, we can expect further advancements in the field of obesity treatment and prevention, bringing us closer to a healthier future for all.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>And stroke risks. Novo Nordisk&#8217;s drug can now be prescribed for this purpose<\/p>\n","protected":false},"author":2196,"featured_media":2196406,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/c3.oann.com\/wp-content\/uploads\/2024\/03\/231013-wegovy-insurance-weight-loss-kh-2db8d0.webp","fifu_image_alt":"","footnotes":""},"categories":[542],"tags":[],"class_list":["post-2196405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oann"],"fifu_image_url":"https:\/\/c3.oann.com\/wp-content\/uploads\/2024\/03\/231013-wegovy-insurance-weight-loss-kh-2db8d0.webp","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2196405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/2196"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2196405"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2196405\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2196406"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2196405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2196405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2196405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}